Leukemia relapse study halted: could a blood test have predicted it?
NCT ID NCT05224661
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a sensitive molecular test could predict relapse in adults with acute myeloid leukemia (AML) who had a stem cell transplant. Researchers planned to follow 303 patients in remission, comparing outcomes between those with and without detectable disease markers. The study was terminated early, so its full potential remains unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA IN REMISSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98109, United States
-
H. Lee Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10021, United States
-
New York Presbyterian / Weill Cornell Medical Center
New York, New York, 10021, United States
-
Northside Hospital
Atlanta, Georgia, 30342, United States
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263, United States
-
Stanford University
Stanford, California, 94305, United States
-
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Chicago Medicine
Chicago, Illinois, 60637, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of Miami
Miami, Florida, 33136, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States